Refining breast cancer genetic risk and biology through multi-ancestry fine-mapping analyses of 192 risk regions

被引:0
|
作者
Jia, Guochong [1 ]
Chen, Zhishan [1 ]
Ping, Jie [1 ]
Cai, Qiuyin [1 ]
Tao, Ran [2 ]
Li, Chao [1 ]
Bauer, Joshua A. [3 ]
Xie, Yuhan [4 ]
Ambs, Stefan [5 ]
Barnard, Mollie E. [6 ]
Chen, Yu [7 ]
Choi, Ji-Yeob [8 ,9 ]
Gao, Yu-Tang [10 ,11 ]
Garcia-Closas, Montserrat [12 ]
Gu, Jian [13 ]
Hu, Jennifer J. [14 ]
Iwasaki, Motoki [15 ]
John, Esther M. [16 ,17 ]
Kweon, Sun-Seog [18 ,19 ]
Li, Christopher I. [20 ]
Matsuda, Koichi [21 ]
Matsuo, Keitaro [22 ,23 ]
Nathanson, Katherine L. [24 ,25 ]
Nemesure, Barbara [26 ]
Olopade, Olufunmilayo I. [27 ]
Pal, Tuya [28 ]
Park, Sue K. [9 ,29 ,30 ]
Park, Boyoung [31 ]
Press, Michael F. [32 ]
Sanderson, Maureen [33 ]
Sandler, Dale P. [34 ]
Shen, Chen-Yang [35 ,36 ]
Troester, Melissa A. [37 ]
Yao, Song [38 ]
Zheng, Ying [39 ]
Ahearn, Thomas [12 ]
Brewster, Abenaa M. [40 ]
Falusi, Adeyinka [41 ]
Hennis, Anselm J. M. [26 ,42 ]
Ito, Hidemi [43 ,44 ]
Kubo, Michiaki [45 ]
Lee, Eun-Sook [46 ,47 ]
Makumbi, Timothy [48 ]
Ndom, Paul [49 ]
Noh, Dong-Young [50 ,51 ]
O'Brien, Katie M. [34 ]
Ojengbede, Oladosu [52 ]
Olshan, Andrew F. [37 ]
Park, Min-Ho [53 ]
Reid, Sonya [54 ]
机构
[1] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Vanderbilt Ingram Canc Ctr, Med Ctr,Dept Med,Div Epidemiol, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA
[3] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Dept Biochem, Nashville, TN 37240 USA
[4] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA
[5] NCI, Ctr Canc Res, Lab Human Carcinogenesis, NIH, Bethesda, MD USA
[6] Boston Univ, Slone Epidemiol Ctr, Boston, MA USA
[7] NYU Grossman Sch Med, Dept Populat Hlth, Div Biostat, New York, NY USA
[8] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea
[9] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea
[10] Shanghai Jiaotong Univ Sch Med, Shanghai Canc Inst, Renji Hosp, State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China
[11] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, Sch Med,Dept Epidemiol, Shanghai, Peoples R China
[12] NCI, Div Canc Epidemiol & Genet, Bethesda, MD USA
[13] Univ Texas, Md Anderson Canc Ctr, Houston, TX USA
[14] Univ Miami, Sch Med, Dept Publ Hlth Sci, Miami, FL USA
[15] Natl Canc Ctr, Inst Canc Control, Div Epidemiol, Tokyo, Japan
[16] Stanford Univ, Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA USA
[17] Stanford Univ, Sch Med, Dept Med, Stanford, CA USA
[18] Chonnam Natl Univ, Med Sch, Dept Prevent Med, Hwasun, South Korea
[19] Chonnam Natl Univ, Hwasun Hosp, Jeonnam Reg Canc Ctr, Hwasun, South Korea
[20] Fred Hutchinson Canc Ctr, Div Publ Hlth Sci, Seattle, WA USA
[21] Univ Tokyo, Grad Sch Frontier Sci, Lab Clin Genome Sequencing, Tokyo, Japan
[22] Aichi Canc Ctr Res Inst, Div Canc Epidemiol & Prevent, Nagoya, Japan
[23] Nagoya Univ, Grad Sch Med, Div Canc Epidemiol, Nagoya, Japan
[24] Univ Penn, Perelman Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA USA
[25] Univ Penn, Perelman Sch Med, Basser Ctr BRCA, Abramson Canc Ctr, Philadelphia, PA USA
[26] SUNY Stony Brook, Renaissance Sch Med, Dept Family Populat & Prevent Med, Stony Brook, NY USA
[27] Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, Chicago, IL USA
[28] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr Dept Med, Med Ctr, Dept Med,Div Genet Med, Nashville, TN 37232 USA
[29] Seoul Natl Univ, Coll Med, Integrated Major Innovat Med Sci, Seoul, South Korea
[30] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
[31] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul, South Korea
[32] Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA USA
[33] Meharry Med Coll, Dept Family & Community Med, Nashville, TN USA
[34] Natl Inst Environm Hlth Sci, NIH, Epidemiol Branch, Res Triangle Pk, NC USA
[35] China Med Univ, Coll Publ Hlth, Taichong, Taiwan
[36] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan
[37] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Dept Epidemiol, Chapel Hill, NC USA
[38] Roswell Pk Comprehens Canc Ctr, Dept Canc Prevent & Control, Buffalo, NY USA
[39] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China
[40] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX USA
[41] Univ Ibadan, Inst Adv Med Res & Training, Coll Med, Genet & Bioeth Res Unit, Ibadan, Nigeria
[42] Univ West Indies, George Alleyne Chron Dis Res Ctr, Bridgetown, Barbados
[43] Aichi Canc Ctr Res Inst, Div Canc Informat & Control, Nagoya, Japan
[44] Nagoya Univ, Grad Sch Med, Dept Descript Canc Epidemiol, Nagoya, Japan
[45] RIKEN Ctr Integrat Med Sci, Yokohama, Japan
[46] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, South Korea
[47] Natl Canc Ctr, Hosp, Goyang, Gyeonggi, South Korea
[48] Mulago Hosp, Dept Surg, Kampala, Uganda
[49] Yaounde Gen Hosp, Yaounde, Cameroon
[50] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea
基金
美国国家卫生研究院;
关键词
GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; IDENTIFIES; VARIANTS; EXPRESSION; ENHANCERS; DATABASE; WOMEN; EQTL;
D O I
10.1038/s41588-024-02031-y
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genome-wide association studies have identified approximately 200 genetic risk loci for breast cancer, but the causal variants and target genes are mostly unknown. We sought to fine-map all known breast cancer risk loci using genome-wide association study data from 172,737 female breast cancer cases and 242,009 controls of African, Asian and European ancestry. We identified 332 independent association signals for breast cancer risk, including 131 signals not reported previously, and for 50 of them, we narrowed the credible causal variants down to a single variant. Analyses integrating functional genomics data identified 195 putative susceptibility genes, enriched in PI3K/AKT, TNF/NF-kappa B, p53 and Wnt/beta-catenin pathways. Single-cell RNA sequencing or in vitro experiment data provided additional functional evidence for 105 genes. Our study uncovered large numbers of association signals and candidate susceptibility genes for breast cancer, uncovered breast cancer genetics and biology, and supported the value of including multi-ancestry data in fine-mapping analyses.
引用
收藏
页码:80 / 87
页数:17
相关论文
共 50 条
  • [41] Parenting Through Genetic Uncertainty: Themes in the Disclosure of Breast Cancer Risk Information to Children
    Sharff, McKane E.
    DeMarco, Tiffani A.
    Mays, Darren
    Peshkin, Beth N.
    Valdimarsdottir, Heiddis B.
    Garber, Judy E.
    Schneider, Katherine A.
    Patenaude, Andrea F.
    Tercyak, Kenneth P.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (05) : 376 - 382
  • [42] FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation
    Udler, Miriam S.
    Meyer, Kerstin B.
    Pooley, Karen A.
    Karlins, Eric
    Struewing, Jeffery P.
    Zhang, Jinghui
    Doody, David R.
    MacArthur, Stewart
    Tyrer, Jonathan
    Pharoah, Paul D.
    Luben, Robert
    Bernstein, Leslie
    Kolonel, Laurence N.
    Henderson, Brian E.
    Le Marchand, Loic
    Ursin, Giske
    Press, Michael F.
    Brennan, Paul
    Sangrajrang, Suleeporn
    Gaborieau, Valerie
    Odefrey, Fabrice
    Shen, Chen-Yang
    Wu, Pei-Ei
    Wang, Hui-Chun
    Kang, Daehee
    Yoo, Keun-Young
    Noh, Dong-Young
    Ahn, Sei-Hyun
    Ponder, Bruce A. J.
    Haiman, Christopher A.
    Malone, Kathleen E.
    Dunning, Alison M.
    Ostrander, Elaine A.
    Easton, Douglas F.
    HUMAN MOLECULAR GENETICS, 2009, 18 (09) : 1692 - 1703
  • [43] Genetic Variants of IDE-KIF11-HHEX at 10q23.33 Associated with Type 2 Diabetes Risk: A Fine-Mapping Study in Chinese Population
    Qian, Yun
    Lu, Feng
    Dong, Meihua
    Lin, Yudi
    Li, Huizhang
    Chen, Jian
    Shen, Chong
    Jin, Guangfu
    Hu, Zhibin
    Shen, Hongbing
    PLOS ONE, 2012, 7 (04):
  • [44] Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
    Zeng, Chenjie
    Guo, Xingyi
    Long, Jirong
    Kuchenbaecker, Karoline B.
    Droit, Arnaud
    Michailidou, Kyriaki
    Ghoussaini, Maya
    Kar, Siddhartha
    Freeman, Adam
    Hopper, John L.
    Milne, Roger L.
    Bolla, Manjeet K.
    Wang, Qin
    Dennis, Joe
    Agata, Simona
    Ahmed, Shahana
    Aittomaki, Kristiina
    Andrulis, Irene L.
    Anton-Culver, Hoda
    Antonenkova, Natalia N.
    Arason, Adalgeir
    Arndt, Volker
    Arun, Banu K.
    Arver, Brita
    Bacot, Francois
    Barrowdale, Daniel
    Baynes, Caroline
    Beeghly-Fadiel, Alicia
    Benitez, Javier
    Bermisheva, Marina
    Blomqvist, Carl
    Blot, William J.
    Bogdanova, Natalia V.
    Bojesen, Stig E.
    Bonanni, Bernardo
    Borresen-Dale, Anne-Lise
    Brand, Judith S.
    Brauch, Hiltrud
    Brennan, Paul
    Brenner, Hermann
    Broeks, Annegien
    Bruening, Thomas
    Burwinkel, Barbara
    Buys, Saundra S.
    Cai, Qiuyin
    Caldes, Trinidad
    Campbell, Ian
    Carpenter, Jane
    Chang-Claude, Jenny
    Choi, Ji-Yeob
    BREAST CANCER RESEARCH, 2016, 18
  • [45] Genetic Variations in miR-30 Family Member Regulatory Regions Are Associated with Breast Cancer Risk in a Chinese Population
    Zhou, Jing
    Wang, Lijuan
    Liu, Sijun
    Zhou, Wen
    Jiang, Yue
    Du, Jiangbo
    Dai, Juncheng
    Jin, Guangfu
    Ma, Hongxia
    Hu, Zhibin
    Chen, Jiaping
    Shen, Hongbing
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [46] An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping
    Thillaiyampalam, Gayathri
    Liberante, Fabio
    Murray, Liam
    Cardwell, Chris
    Mills, Ken
    Zhang, Shu-Dong
    BMC BIOINFORMATICS, 2017, 18
  • [47] Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1
    Meyer, Kerstin B.
    O'Reilly, Martin
    Michailidou, Kyriaki
    Carlebur, Saskia
    Edwards, Stacey L.
    French, Juliet D.
    Prathalingham, Radhika
    Dennis, Joe
    Bolla, Manjeet K.
    Wang, Qin
    de Santiago, Ines
    Hopper, John L.
    Tsimiklis, Helen
    Apicella, Carmel
    Southey, Melissa C.
    Schmidt, Marjanka K.
    Broeks, Annegien
    Van't Veer, Laura J.
    Hogervorst, Frans B.
    Muir, Kenneth
    Lophatananon, Artitaya
    Stewart-Brown, Sarah
    Siriwanarangsan, Pornthep
    Fasching, Peter A.
    Lux, Michael P.
    Ekici, Arif B.
    Beckmann, Matthias W.
    Peto, Julian
    Silva, Isabel dos Santos
    Fletcher, Olivia
    Johnson, Nichola
    Sawyer, Elinor J.
    Tomlinson, Ian
    Kerin, Michael J.
    Miller, Nicola
    Marme, Federick
    Schneeweiss, Andreas
    Sohn, Christof
    Burwinkel, Barbara
    Guenel, Pascal
    Truong, Therese
    Laurent-Puig, Pierre
    Menegaux, Florence
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    Nielsen, Sune F.
    Flyger, Henrik
    Milne, Roger L.
    Pilar Zamora, M.
    Arias, Jose I.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2013, 93 (06) : 1046 - 1060
  • [48] Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry
    Yang, Yaohua
    Shu, Xiang
    Shu, Xiao-ou
    Bolla, Manjeet K.
    Kweon, Sun-Seog
    Cai, Qiuyin
    Michailidou, Kyriaki
    Wang, Qin
    Dennis, Joe
    Park, Boyoung
    Matsuo, Keitaro
    Kwong, Ava
    Park, Sue Kyung
    Wu, Anna H.
    Teo, Soo Hwang
    Iwasaki, Motoki
    Choi, Ji-Yeob
    Li, Jingmei
    Hartman, Mikael
    Shen, Chen-Yang
    Muir, Kenneth
    Lophatananon, Artitaya
    Li, Bingshan
    Wen, Wanqing
    Gao, Yu-Tang
    Xiang, Yong-Bing
    Aronson, Kristan J.
    Spinell, John J.
    Gago-Dominguez, Manuela
    John, Esther M.
    Kurian, Allison W.
    Chang-Claude, Jenny
    Chen, Shou-Tung
    Dork, Thilo
    Evans, D. Gareth R.
    Schmidt, Marjanka K.
    Shin, Min-Ho
    Giles, Graham G.
    Milne, Roger L.
    Simard, Jacques
    Kubo, Michiaki
    Kraft, Peter
    Kang, Daehee
    Easton, Douglas F.
    Zheng, Wei
    Long, Jirong
    EBIOMEDICINE, 2019, 48 : 203 - 211
  • [49] Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1
    Glubb, Dylan M.
    Maranian, Mel J.
    Michailidou, Kyriaki
    Pooley, Karen A.
    Meyer, Kerstin B.
    Kar, Siddhartha
    Carlebur, Saskia
    O'Reilly, Martin
    Betts, Joshua A.
    Hillman, Kristine M.
    Kaufmann, Susanne
    Beesley, Jonathan
    Canisius, Sander
    Hopper, John L.
    Southey, Melissa C.
    Tsimiklis, Helen
    Apicella, Carmel
    Schmidt, Marjanka K.
    Broeks, Annegien
    Hogervorst, Frans B.
    van der Schoot, C. Ellen
    Muir, Kenneth
    Lophatananon, Artitaya
    Stewart-Brown, Sarah
    Siriwanarangsan, Pornthep
    Fasching, Peter A.
    Ruebner, Matthias
    Ekici, Arif B.
    Beckmann, Matthias W.
    Peto, Julian
    Dos-Santos-Silva, Isabel
    Fletcher, Olivia
    Johnson, Nichola
    Pharoah, Paul D. P.
    Bolla, Manjeet K.
    Wang, Qin
    Dennis, Joe
    Sawyer, Elinor J.
    Tomlinson, Ian
    Kerin, Michael J.
    Miller, Nicola
    Burwinkel, Barbara
    Marme, Frederik
    Yang, Rongxi
    Surowy, Harald
    Guenel, Pascal
    Truong, Therese
    Menegaux, Florence
    Sanchez, Marie
    Bojesen, Stig E.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2015, 96 (01) : 5 - 20
  • [50] Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families
    Desjardins, Sylvie
    Belleau, Pascal
    Labrie, Yvan
    Ouellette, Genevieve
    Bessette, Paul
    Chiquette, Jocelyne
    Laframboise, Rachel
    Lepine, Jean
    Lesperance, Bernard
    Pichette, Roxane
    Plante, Marie
    Durocher, Francine
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (01) : 108 - 116